ARL6IP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.080400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.253600E-01
Normal-vs-Stage2
1.735640E-01
Normal-vs-Stage3
6.341000E-01
Normal-vs-Stage4
1.655380E-01
Stage1-vs-Stage2
3.864600E-01
Stage1-vs-Stage3
8.991400E-01
Stage1-vs-Stage4
2.239800E-01
Stage2-vs-Stage3
3.862800E-01
Stage2-vs-Stage4
2.756800E-01
Stage3-vs-Stage4
3.102400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.274400E-01
Normal-vs-AfricanAmerican
3.470200E-01
Normal-vs-Asian
2.217800E-01
Caucasian-vs-AfricanAmerican
9.719800E-01
Caucasian-vs-Asian
4.930600E-01
AfricanAmerican-vs-Asian
7.025200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.425600E-01
Normal-vs-Female
1.782840E-01
Male-vs-Female
9.760600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.382000E-01
Normal-vs-Age(41-60Yrs)
1.590640E-01
Normal-vs-Age(61-80Yrs)
2.421200E-01
Normal-vs-Age(81-100Yrs)
2.060400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.504800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.496400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.296200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.632200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.749600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.873400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.200400E-01
Normal-vs-Daily Drinker
2.683600E-01
Normal-vs-Weekly Drinker
4.378200E-01
Normal-vs-Occasional Drinker
2.072800E-01
Normal-vs-Social Drinker
1.481390E-01
Non Drinker-vs-Daily Drinker
6.385200E-01
Non Drinker-vs-Weekly Drinker
7.277400E-01
Non Drinker-vs-Occasional Drinker
5.409800E-01
Non Drinker-vs-Social Drinker
6.254800E-01
Daily Drinker-vs-Weekly Drinker
9.934600E-01
Daily Drinker-vs-Occasional Drinker
8.824400E-01
Daily Drinker-vs-Social Drinker
9.643600E-01
Weekly Drinker-vs-Occasional Drinker
9.134000E-01
Weekly Drinker-vs-Social Drinker
9.685800E-01
Occasional Drinker-vs-Social Drinker
9.123000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.706590E-01
Normal-vs-Grade 2
4.016200E-02
Normal-vs-Grade 3
4.790000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.378000E-03
Grade 1-vs-Grade 3
1.012090E-02
Grade 1-vs-Grade 4
1.706590E-01
Grade 2-vs-Grade 3
6.457400E-01
Grade 2-vs-Grade 4
4.016200E-02
Grade 3-vs-Grade 4
4.790000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.756000E-01
Normal-vs-NonDiabetic
1.742050E-01
Diabetic-vs-NonDiabetic
3.383400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.401020E-01
Normal-vs-NoPancreatitis
2.289000E-01
Pancreatitis-vs-NoPancreatitis
5.036800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.297000E-01
Normal-vs-N1
1.799550E-01
N0-vs-N1
3.626800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.195700E-02
Normal-vs-TP53-NonMutant
4.999200E-01
TP53-Mutant-vs-TP53-NonMutant
4.836300E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
